Evidence map›Paper›PMID 27788145›Full record

ArticlePloS one2016

Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.

Richard Jay Smeyne, Charles B Breckenridge, Melissa Beck, Yun Jiao, Mark T Butt, Jeffrey C Wolf, Dan Zadory, Daniel J Minnema, Nicholas C Sturgess, Kim Z Travis and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 95 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Preventing Parkinson's Disease: An Environmental Agenda.Journal of Parkinson's disease · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Richard Jay SmeyneSt. Jude Children's Research Hospital, Dept. of Developmental Neurobiology, 262 Danny Thomas Place, Memphis, TN 38105, United States of America.
Charles B BreckenridgeSyngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC 27419-8300, United States of America.
Melissa BeckWIL Research Laboratories, LLC., Ashland, OH 44805, United States of America.
Yun JiaoSt. Jude Children's Research Hospital, Dept. of Developmental Neurobiology, 262 Danny Thomas Place, Memphis, TN 38105, United States of America.
Mark T ButtTox Path Specialists, LLC, 8747 Chestnut Grove Road, Frederick, MD 21701-2607, United States of America.
Jeffrey C WolfExperimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA 20166, United States of America.
Dan ZadoryExperimental Pathology Laboratories, Inc., 45600 Terminal Drive, Sterling, VA 20166, United States of America.
Daniel J MinnemaSyngenta Crop Protection, LLC, P.O. Box 18300, Greensboro, NC 27419-8300, United States of America.
Nicholas C SturgessSyngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.
Kim Z TravisSyngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.
Andrew R CookSyngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.
Lewis L SmithUniversity of Leicester, University Road, Leicester LE1 7RH, United Kingdom.
Philip A BothamSyngenta Limited, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.
Syngenta (United Kingdom) · GBExperimental Pathology Laboratories · USSt. Jude Children's Research Hospital · USSyngenta (United States) · USAshland (United States) · USUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurotoxicity of paraquat dichloride (PQ) was assessed in two inbred strains of 9- or 16-week old male C57BL/6 mice housed in two different laboratories and compared to the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). PQ was administered by intraperitoneal injections; either once (20 mg/kg) or twice (10 mg/kg) weekly for 3 weeks, while MPTP-HCl was injected 4 times on a single day (20 mg/kg/dose). Brains were collected 8, 16, 24, 48, 96 or 168 hours after the last PQ treatment, and 48 or 168 hours after MPTP treatment. Dopamine neurons in the substantia nigra pars compacta (SNpc) were identified by antibodies to tyrosine hydroxylase (TH+) and microglia were identified using Iba-1 immunoreactivity. The total number of TH+ neurons and the number of resting and activated microglia in the SNpc at 168 hours after the last dose were estimated using model- or design-based stereology, with investigators blinded to treatment. In a further analysis, a pathologist, also blinded to treatment, evaluated the SNpc and/or striatum for loss of TH+ neurons (SNpc) or terminals (striatum), cell death (as indicated by amino cupric silver uptake, TUNEL and/or caspase 3 staining) and neuroinflammation (as indicated by Iba-1 and/or GFAP staining). PQ, administered either once or twice weekly to 9- or 16-week old mice from two suppliers, had no effect on the number of TH+ neurons or microglia in the SNpc, as assessed by two groups, each blinded to treatment, using different stereological methods. PQ did not induce neuronal cell loss or degeneration in the SNpc or striatum. Additionally, there was no evidence of apoptosis, microgliosis or astrogliosis. In MPTP-treated mice, the number of TH+ neurons in the SNpc was significantly decreased and the number of activated microglia increased. Histopathological assessment found degenerating neurons/terminals in the SNpc and striatum but no evidence of apoptotic cell death. MPTP activated microglia in the SNpc and increased the number of astrocytes in the SNpc and striatum.

Indexed as

AnimalsBody WeightCell CountDopaminergic NeuronsEatingMaleMiceMice, Inbred C57BLMicrogliaMPTP PoisoningParaquatPars CompactaSurvival AnalysisTyrosine 3-MonooxygenaseParaquatTyrosine 3-Monooxygenase

Identifiers

PMID27788145
PMCPMC5082881
OpenAlexW2539841050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.